Search clinical trials for: 300 mg inclisiran sodium (equivalent to 284 mg inclisiran)
Total 318 results
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsRecruitingPrimary Prevention of Atherosclerotic Cardiovascular DiseaseUnited States, China, Italy, Spain, Canada, France, Netherlands, Switzerland, Taiwan, Greece, Thailand, Brazil, India, Hungary, Latvia, Mexico, Israel, Turkey, Argentina, Singapore, Australia, Belgium, Bulgaria, Denmark, Croatia, South Africa and more
-
Novartis PharmaceuticalsActive, not recruitingAtherosclerotic Cardiovascular DiseaseUnited States, China, South Africa, Spain, Austria, Belgium, Croatia, Estonia, Hungary, Taiwan, Turkey, Netherlands, Italy, Australia, Czechia, Denmark, France, Israel, Korea, Republic of, Thailand, Argentina, Bulgaria, Greece, Romania, Sloveni... and more
-
Novartis PharmaceuticalsRecruitingCoronary Artery DiseaseUnited States, Italy, Spain, France, Korea, Republic of, Hungary, Japan, Argentina, China, India, Belgium, Switzerland, United Kingdom, Canada, Australia, Brazil, Chile, Ireland
-
University of California, San FranciscoSan Francisco VA Health Care SystemCompletedAlcohol Use DisorderUnited States
-
McGill University Health Centre/Research Institute...RecruitingESRD | CKD Stage 4 | CKD Stage 5Canada
-
Mylan Pharmaceuticals IncCompletedHealthyUnited States
-
Janssen Research & Development, LLCCompleted
-
RespireRxDuke UniversityUnknownOpiate Induced Respiratory DepressionUnited States
-
ObsEva SATerminatedEndometriosisUnited States, Canada, Puerto Rico
-
Kissei Pharmaceutical Co., Ltd.CompletedEndometriosisUnited States, Austria, Bulgaria, Czechia, France, Poland, Romania, Spain, Ukraine
-
Kissei Pharmaceutical Co., Ltd.TerminatedEndometriosisUnited States, Canada, Puerto Rico
-
Kissei Pharmaceutical Co., Ltd.CompletedEndometriosisUnited States, Austria, Bulgaria, Czechia, France, Poland, Romania, Spain, Ukraine, Hungary
-
PfizerTerminatedPlaque PsoriasisUnited States, Canada
-
AstraZenecaActive, not recruitingMetastatic Triple Negative Breast CancerUnited States, Belgium, Italy, Spain, United Kingdom, Canada, Czechia, Poland, France, Korea, Republic of, Germany, Taiwan, Portugal, Netherlands, Ireland
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Hope PharmaceuticalsTerminatedSubarachnoid HemorrhageUnited States
-
Clarus Therapeutics, Inc.Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical CenterCompletedHypogonadismUnited States
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States, Brazil
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedDiabetes Mellitus, Type 2United States
-
Sprout Pharmaceuticals, IncTerminatedDepression | Sexual Dysfunctions, PsychologicalUnited States
-
Novartis PharmaceuticalsCompletedPruritus in Patients With Atopic DermatitisGermany
-
Rigel PharmaceuticalsNo longer availableImmune Thrombocytopenic Purpura
-
Merck Sharp & Dohme LLCCompleted
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States
-
Janssen Research & Development, LLCThe George Institute for Global Health, AustraliaCompletedDiabetes Mellitus, Type 2 | AlbuminuriaAustralia, France, Italy, Poland, Ukraine, United Kingdom, United States, China, Belgium, Germany, Taiwan, Spain, Argentina, Mexico, Malaysia, Canada, Netherlands, Korea, Republic of, New Zealand, Brazil, Russian Federation, Puerto... and more
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 1United States, Canada
-
Boehringer IngelheimCompleted
-
AstraZenecaCompletedCardiovascular Disease | Healthy Male SubjectsUnited Kingdom
-
University Hospital, ToulouseTerminated
-
Genzyme, a Sanofi CompanyTerminated
-
Frank LippertThe Borrow FoundationCompleted
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Assistance Publique - Hôpitaux de ParisMerck Sharp & Dohme LLC; Pfizer; AstraZenecaCompletedIschemic Stroke | Transient Ischemic Attack | Atherosclerotic StenosisFrance
-
Idorsia Pharmaceuticals Ltd.Completed
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States, Ukraine, Argentina, Mexico, Romania, South Africa, Korea, Republic of, Russian Federation, Brazil, Puerto Rico, Hungary, Slovakia, Czechia
-
Lexicon PharmaceuticalsCompletedType 2 Diabetes MellitusUnited States
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCThe George Institute for Global Health, AustraliaCompletedCardiovascular Diseases | Diabetes Mellitus, Type 2 | Risk FactorsUnited States, Australia, Poland, Ukraine, United Kingdom, Belgium, Germany, France, Spain, Argentina, Colombia, Israel, Mexico, India, Canada, Netherlands, Sweden, Malaysia, New Zealand, Estonia, Russian Federation, Hungary, Norway, ... and more
-
Genentech, Inc.CompletedSolid TumorUnited Kingdom
-
Idorsia Pharmaceuticals Ltd.CompletedHealthy SubjectsUnited Kingdom
-
Jupiter Orphan Therapeutics Inc.National Institute on Aging (NIA)CompletedPharmacokinetics | Food-drug Interaction | SafetyUnited States
-
Rigel PharmaceuticalsWithdrawn
-
Universidade Federal do CearáConselho Nacional de Desenvolvimento Científico e Tecnológico; São José Hospital... and other collaboratorsRecruiting
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Swiss Tropical & Public Health InstitutePublic Health Laboratory Ivo de CarneriCompletedTrichuris Trichiura; InfectionTanzania
-
NovartisCompletedHypertensionEstonia, France, Iceland, India, Italy, Korea, Republic of, Lithuania, Spain, Venezuela
-
Merck Sharp & Dohme LLCPfizerCompletedHypertension | Diabetes Mellitus, Type 2
-
CytokineticsRecruitingObstructive Hypertrophic Cardiomyopathy (oHCM)United States, Denmark, Spain, Netherlands, United Kingdom, France, China, Israel, Germany, Italy, Hungary, Canada